Breaking News, Financial News

Financial Report: West Pharmaceutical Services

Revenues up 2% in the quarter, partially offset by the voluntary recall of Vial2Bag

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

West Pharmaceutical Services 4Q Revenues:$422.5 million (+2%) 4Q Earnings: $52.0 million (n/a) FY Revenues: $1.7 billion (+7%) FY Earnings: $206.9 million (+37%) Comments: Proprietary Products segment sales were up 2%, led by growth in Biologics and Generics market units. Pharma market sales were flat, affected by the voluntary recall of Vial2Bag due to reports of potential variable dosing associated with the Vial2Bag DC 13 mm device. High-value product (HVP) sales growth was 1%, led by Nov...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters